| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Ceribell, Inc. | Director | Common Stock | 2,475,110 | $41,037,323 | $16.58 | 10 Jun 2025 | By Longitude Venture Partners IV, L.P. |
| RxSight, Inc. | Director | Common Stock | 48,146 | $628,786 | $13.06 | 03 Jun 2025 | Direct |
| Ceribell, Inc. | Director | Common Stock | 15,446 | $256,094 | $16.58 | 10 Jun 2025 | Direct |
| RxSight, Inc. | Director | Common Stock | 1,548 | $20,216 | $13.06 | 03 Jun 2025 | Indirect |
| Eargo, Inc. | Director, 10%+ Owner | Common Stock | 7,016 | $18,171 | $2.59 | 17 May 2021 | Direct |
| Eargo, Inc. | Director, 10%+ Owner | Common Stock | 3,008 | $7,791 | $2.59 | 17 May 2021 | Indirect |
| Ceribell, Inc. | Director | Series C-1 Preferred Stock | 0 | 15 Oct 2024 | By Longitude Venture Partners IV, L.P. |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CBLL | Ceribell, Inc. | 10 Jun 2025 | 1 | $0 | 4 | Director | 17 Jun 2025, 19:50 |
| RXST | RxSight, Inc. | 03 Jun 2025 | 1 | $0 | 4 | Director | 04 Jun 2025, 21:33 |
| CBLL | Ceribell, Inc. | 11 Oct 2024 | 4 | +$4,032,978 | 4 | Director | 16 Oct 2024, 16:18 |
| CBLL | Ceribell, Inc. | 10 Oct 2024 | 0 | $0 | 3 | Director | 10 Oct 2024, 16:17 |
| RXST | RxSight, Inc. | 06 Jun 2024 | 1 | $0 | 4 | Director | 10 Jun 2024, 16:07 |
| RXST | RxSight, Inc. | 17 May 2024 | 1 | +$305,456 | 4 | Director | 21 May 2024, 16:11 |
| RXST | RxSight, Inc. | 12 Feb 2024 | 2 | +$406,673 | 4 | Director | 15 Feb 2024, 16:15 |
| RXST | RxSight, Inc. | 28 Nov 2023 | 5 | -$14,695,695 | 4 | Director | 30 Nov 2023, 19:32 |
| RXST | RxSight, Inc. | 14 Nov 2023 | 2 | -$13,590,750 | 4 | Director | 16 Nov 2023, 19:31 |
| RXST | RxSight, Inc. | 07 Sep 2023 | 3 | -$992,969 | 4 | Director | 11 Sep 2023, 18:15 |
| RXST | RxSight, Inc. | 24 Aug 2023 | 4 | -$474,129 | 4 | Director | 28 Aug 2023, 19:44 |
| RXST | RxSight, Inc. | 17 Aug 2023 | 2 | -$981,570 | 4 | Director | 18 Aug 2023, 16:08 |
| RXST | RxSight, Inc. | 09 Aug 2023 | 2 | $0 | 4 | Director | 11 Aug 2023, 16:13 |
| RXST | RxSight, Inc. | 14 Jun 2023 | 3 | $0 | 4 | Director | 16 Jun 2023, 16:49 |
| RXST | RxSight, Inc. | 01 Jun 2023 | 1 | $0 | 4 | Director | 05 Jun 2023, 16:36 |
| RXST | RxSight, Inc. | 26 May 2023 | 2 | $0 | 4 | Director | 31 May 2023, 18:09 |
| RXST | RxSight, Inc. | 10 Feb 2023 | 1 | +$6,000,000 | 4 | Director | 13 Feb 2023, 17:20 |
| RXST | RxSight, Inc. | 02 Jun 2022 | 1 | $0 | 4 | Director | 03 Jun 2022, 20:24 |
| RXST | RxSight, Inc. | 03 Aug 2021 | 10 | +$10,200,000 | 4 | Director | 05 Aug 2021, 19:41 |
| RXST | RxSight, Inc. | 30 Jul 2021 | 1 | $0 | 4 | Director | 02 Aug 2021, 20:17 |
| RXST | RxSight, Inc. | 29 Jul 2021 | 0 | $0 | 3 | Director | 29 Jul 2021, 10:42 |
| /report/000089924321019943-tammenoms-bakker-juliet-2021-05-17 | Eargo, Inc. | 17 May 2021 | 3 | $0 | 4 | Director, 10%+ Owner | 19 May 2021, 16:58 |